Soleus Capital Management’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,350
Closed -$4.43M 86
2024
Q3
$4.43M Sell
50,350
-27,676
-35% -$2.32M 0.37% 63
2024
Q2
$5.34M Sell
78,026
-3,278
-4% -$390K 0.47% 60
2024
Q1
$14M Hold
81,304
1.23% 30
2023
Q4
$10M Sell
81,304
-5,820
-7% -$505K 1.11% 29
2023
Q3
$7.41M Buy
87,124
+700
+0.8% +$89.2K 0.75% 40
2023
Q2
$13M Hold
86,424
1.44% 19
2023
Q1
$11.6M Buy
86,424
+2,016
+2% +$363K 1.43% 24
2022
Q4
$34.8M Buy
84,408
+16,398
+24% +$6.8M 5% 4
2022
Q3
$26.2M Buy
68,010
+2,756
+4% +$902K 3.56% 7
2022
Q2
$9.3M Buy
65,254
+14,946
+30% +$2.38M 1.49% 25
2022
Q1
$12.6M Hold
50,308
1.94% 23
2021
Q4
$49.4M Hold
50,308
6.66% 5
2021
Q3
$74.1M Sell
50,308
-5,577
-10% -$10.9M 11.54% 1
2021
Q2
$118M Sell
55,885
-7,702
-12% -$17.4M 18.21% 1
2021
Q1
$162M Hold
63,587
29.12% 1
2020
Q4
$108M Buy
+63,587
New +$106M 30.02% 2

Other funds holding BCAB